Results 151 to 160 of about 43,735 (227)

Multivalent antibody‐based conjugates as new tools for tailored modulation of G protein–coupled receptors

open access: yesBritish Journal of Pharmacology, Volume 183, Issue 16, Page 4512-4531, August 2026.
The G protein–coupled receptor (GPCR) superfamily consists of the most common targets of approved drugs. Targeting GPCRs offers appealing avenues for therapeutic development. Antibodies and their fragments, such as single‐domain antibodies (VHHs or nanobodies), have emerged as useful alternatives to small molecule pharmacophores as building blocks in ...
Shivani Sachdev, Ross W. Cheloha
wiley   +1 more source

Arecae pericarpium extract induces porcine lower-esophageal-sphincter contraction via muscarinic receptors. [PDF]

open access: yesBMC Complement Med Ther, 2021
Tey SL   +7 more
europepmc   +1 more source

Decoding Brain Development and Function Through GABAergic Inhibitory Neurons

open access: yesEuropean Journal of Neuroscience, Volume 64, Issue 3, August 2026.
Interneuron subtype specification occurs case by case. Whereas some interneurons are specified very early, at the progenitor level, other interneurons develop final features during migration into the migratory stream or upon integration into specific cortical layers. The concept that interneuron specification can be significantly influenced by external
Renata Batista‐Brito   +3 more
wiley   +1 more source

Muscarinic receptors mediate motivation via preparatory neural activity in humans. [PDF]

open access: yesElife
Grogan JP   +5 more
europepmc   +1 more source

Adverse outcomes between VMAT2 and anticholinergics in tardive dyskinesia: A target trial emulation

open access: yesPsychiatry and Clinical Neurosciences, Volume 80, Issue 8, Page 637-644, August 2026.
Aim Vesicular monoamine transporter 2 (VMAT2) inhibitors have been approved for the treatment of tardive dyskinesia (TD), whereas anticholinergic agents are still widely used for this condition. This study aimed to compare the risk of major clinical adverse outcomes among patients with TD treated with VMAT2 inhibitors versus anticholinergic agents ...
Tien‐Wei Hsu   +13 more
wiley   +1 more source

Hepatocellular carcinoma hosts cholinergic neural cells and tumoral hepatocytes harboring targetable muscarinic receptors. [PDF]

open access: yesJHEP Rep
Hernandez CA   +24 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy